Switch to Stribild versus continuation of NVP or RPV with FTC and TDF in virologically suppressed HIV adults: a STRATEGY-NNRTI subgroup analysis.

Stellbrink, Hans-Juergen; Antinori, Andrea; Pozniak, Anton; Flamm, Jason; Bredeek, Fritz; Patel, Kiran; Garner, Will; Piontkowsky, David.

Afiliación

Stellbrink HJ; Infectious Diseases, ICH Study Center, Hamburg, Germany.
Antinori A; Infectious Diseases, Istituto Nazionale Malattie Infettive Lazzaro Spallanzani IRCCS, Rome, Italy.
Pozniak A; HIV Unit, St Stephens Centre, Chelsea and Westminster Hospital, London, UK.
Flamm J; Infectious Diseases, Kaiser Permanente, Sacramento, CA, USA.
Bredeek F; HIV Medicine, Metropolis Medical Group, San Francisco, CA, USA.
Patel K; HIV Division, Gilead Sciences, Foster City, CA, USA.
Garner W; HIV Division, Gilead Sciences, Foster City, CA, USA.
Piontkowsky D; HIV Division, Gilead Sciences, Foster City, CA, USA.

J Int AIDS Soc ; 17(4 Suppl 3): 19793, 2014.

Article en En | MEDLINE | ID: mdl-25397537

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Año: 2014 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Año: 2014 Tipo del documento: Article